Charter Medical Receives CE Mark Clearance for Next Generation Cell Freeze(R) Cryogenic Stem Cell Storage Containers

MANCHESTER, Conn., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Charter Medical, Ltd., a Lydall subsidiary, (NYSE:LDL - News) announced today that it received CE Mark approval on its next generation Cell Freeze(R) Cryogenic Storage Containers for Hematopoietic Progenitor Cells (HPC's). The issuance of the approval by European regulators allows Charter Medical to begin marketing and selling the newly designed and expanded product offering for cryogenic storage, preservation, and transfer of HPC's in Europe. These next generation storage containers offer a broad size range from 50 mL to 750 mL and have excellent durability when frozen at ultralow (-196*C) temperatures.

Joe Petrosky, Vice President of Global Marketing and Sales for Charter Medical, stated: "We are excited at this launch of the Cell-Freeze(R) product family of cryogenic storage containers into Europe. These products serve several high growth markets including cellular therapy and have already received acceptance at several customers in the U.S."

Dale Barnhart, CEO of Lydall, stated: "I am pleased with the launch of this product into Europe which represents a strategic growth opportunity for the Cell-Freeze(R) product line. It demonstrates our commitment to increase our presence globally in the biotech and cellular therapy markets."

About Lydall, Inc.

Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut. The Company, with operations in the U.S., France, the Netherlands and Germany and offices in Europe and Asia, focuses on specialty engineered products for the thermal/acoustical and filtration/separation markets. Charter Medical, Ltd., a Lydall subsidiary, is a vital fluids management company focused on providing products to separate, contain and transport vital fluids in the blood and cell therapy market and the biotech and pharmaceutical industries. Lydall(R) is a registered trademark of Lydall, Inc. in the U.S. and other countries. All product names are trademarks of Lydall, Inc. or Charter Medical, Ltd.

Contact:

For further Charter Medical Information:Dominic Clarke, Ph.D.Product ManagerCellular Therapy and Cryogenic Storage3948-A Westpoint Blvd.Winston-Salem, NC 27103Phone: (336) 768-6447Fax: (336) 774-1750dclarke@lydall.comwww.chartermedical.comErika G. TurnerVice President, Chief Financial Officerand TreasurerTelephone 860.646.1233Facsimile 860.646.8847www.lydall.cominfo@lydall.com